A million Canadians may not know they have COPD, report states Updated guidelines for diagnosis and treatment of community-acquired pneumoniaHighlight 16 key issues to help clinicians optimize therapy for their patients with CAP Symbicort Turbuhaler now approved for “prn” use as “anti-inflammatory reliever therapy” in mild persistent asthma Indicated for 'as needed' use to relieve asthma symptoms when they occur in patients with mild persistent asthma How smoking cessation in heavy smokers affects future cardiovascular risk Study examines time course of cardiovascular disease risk reduction after smoking cessation Key change in managing mild asthma recommended in 2019 GINA guidelines Short-acting bronchodilators used alone “as needed” are no longer recommended for adults or adolescents Pharmacy technicians can assess and correct inhaler technique during inhaler refill pick-ups Pilot study shows benefits of program and identifies potential barriers to expanding this service A helpful guide to creating an asthma action plan for adults Evidence-based tool aids healthcare providers in developing a plan for escalating therapy during acute loss of asthma control Asthma often mismanaged, latest report shows While the majority of asthma patients believe their asthma is under control, 1 million Canadians experience symptoms daily Study shows e-cigarettes more effective than nicotine-replacement therapy for smoking cessation Cautious approach still advised before recommending e-cigs over approved smoking cessation therapies due to several uncertainties US national survey reports alarming increase in use of e-cigarettes by youth Use increased by 78% in high schoolers and by 48% in middle schoolers from 2017 to 2018 First Previous 30 31 32 33 34 Next Last
